CN Stock MarketDetailed Quotes

688319 Chengdu Olymvax Biopharmaceuticals Inc

Watchlist
  • 8.47
  • +0.11+1.32%
Trading Sep 10 14:18 CST
3.44BMarket Cap-88229P/E (TTM)

Chengdu Olymvax Biopharmaceuticals Inc Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Chengdu Olymvax Biopharmaceuticals Inc Q2 2024 Earnings Date

Currency：CNYAug 22, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
--
155.48M
--
-6.52%
Net Income
--
-3.42M
--
-114.21%
Analyst Rating
Strong Buy

Sep 10, 2024

Chengdu Olymvax Biopharmaceuticals Inc Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 825.000M--
--2024/FY-- / 658.000M--
--2023/FY496.119M / 632.763M--
--2022/FY547.481M / 595.000M--
--2021/FY487.152M / 513.000M--
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 825.000M--
--2024/FY-- / 658.000M--
--2023/FY496.119M / 632.763M--
--2022/FY547.481M / 595.000M--
--2021/FY487.152M / 513.000M--

Unlock Free Earnings Estimates

Chengdu Olymvax Biopharmaceuticals Inc Earnings Reports

  • Chengdu Olin Biotechnology Co., Ltd. 2024 Interim Report

    Aug 21 12:00 ET

  • Summary of the semi-annual report of Chengdu Olin Biotechnology Co., Ltd. in 2024.

    Aug 21 12:00 ET

  • Summary of the 2023 Annual Report of Chengdu Olin Biotechnology Co., Ltd.

    Apr 25 12:00 ET

  • Chengdu Olin Biotechnology Co., Ltd. 2023 Annual Report

    Apr 25 12:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Sep 10, 2024

    Strong Buy

    • Strong Buy

      75.00%

    • Buy

      25.00%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    % Chg